Bellus Health Inc. - a GSK company
Quick facts
Phase 3 pipeline
- 3APS · Respiratory
3APS is a selective P2X3 receptor antagonist that blocks pain signaling in sensory neurons to reduce chronic cough. - BLU-5937 · Pain Management / Neurology
BLU-5937 is a selective P2X3 receptor antagonist that blocks pain signaling in sensory neurons. - Tramiprosate (3APS) · Neurology
Tramiprosate inhibits amyloid-beta aggregation and promotes its clearance, reducing amyloid plaque formation in the brain.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: